GSK-29060/276

Study Sponsor: GSK

Study Title

A double-blind study to investigate the efficacy, safety and tolerability of Paroxetine in the treatment of depression in comparison with placebo

Medicine or Vaccine (generic name)

paroxetine

Sponsor Identification Number

29060/276

Trial Registry Identification Number(#'s)

Medical Condition

Depressive Disorder

Phase

Phase 2

Link to GSK Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=29060/276

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

The data from this study is provided in combined datasets containing data from other paroxetine studies. A raw dataset is not available for this study. An annotated case report form and a reporting and analysis plan are not available for this study. A link to ClinicalTrials.gov and an NCTID number are not available for this study because the study is not in scope of regulatory requirements to register studies.

Date Added to this Site

May 2014